Cargando…

Clinical management and associated costs for moderate and severe Alzheimer’s disease in urban China: a Delphi panel study

BACKGROUND: Healthcare resource utilisation for Alzheimer’s disease (AD) in China is not well understood. This Delphi panel study aimed to describe the clinical management pathways for moderate and severe AD patients in urban China and to define the amount and cost of healthcare resources used. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xin, Chen, Shengdi, Chen, Xiaochun, Jia, Jianjun, Li, Chunhou, Liu, Cong, Toumi, Mondher, Milea, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546035/
https://www.ncbi.nlm.nih.gov/pubmed/26301090
http://dx.doi.org/10.1186/s40035-015-0038-9
_version_ 1782386838773694464
author Yu, Xin
Chen, Shengdi
Chen, Xiaochun
Jia, Jianjun
Li, Chunhou
Liu, Cong
Toumi, Mondher
Milea, Dominique
author_facet Yu, Xin
Chen, Shengdi
Chen, Xiaochun
Jia, Jianjun
Li, Chunhou
Liu, Cong
Toumi, Mondher
Milea, Dominique
author_sort Yu, Xin
collection PubMed
description BACKGROUND: Healthcare resource utilisation for Alzheimer’s disease (AD) in China is not well understood. This Delphi panel study aimed to describe the clinical management pathways for moderate and severe AD patients in urban China and to define the amount and cost of healthcare resources used. METHODS: A panel of 11 experts was recruited from urban China to participate in two rounds of preparatory interviews. In the first round, 9 physicians specialised in dementia gave a qualitative description of the clinical management of AD patients. In the second round, 2 hospital administrators were asked about the cost of AD management and care. Results from the interviews were discussed by the experts in a Delphi panel meeting, where consensus was reached on quantitative aspects of AD management, including the rate of healthcare resource utilisation, the respective unit costs and caregiving time. RESULTS: Interviewees reported that mild AD is under-recognised in China; most patients are diagnosed with moderate to severe AD. Loss of independence and agitation/aggression are the main drivers for healthcare resource utilisation and contribute to a heavier caregiver burden. It was estimated that 70 % moderate AD patients are independent/non-aggressive at the time of diagnosis, 15 % are independent/aggressive, 10 % are dependent/non-aggressive, and 5 % are dependent/aggressive. Dependent/aggressive AD patients are more likely to be hospitalised (70–90 %) than accepted in a nursing home (0–20 %), while the opposite is true for dependent/non-aggressive patients (5–35 % for hospitalisation vs. 80 % for nursing home). Independent AD patients require 1–3 hours/day of caregiver time, while dependent patients can require up to 12–15 hours/day. Experts agreed that AD complicates the management of age-related comorbidities, found in 70–80 % of all AD patients, increasing the frequency and cost of hospitalisation. CONCLUSIONS: The Delphi panel approach was an efficient method of gathering data about the amount of healthcare resources used and associated costs for moderate and severe AD patients in urban China. The results of this study provide a useful source of information for decision makers to improve future healthcare policies and resource planning, as well as to perform economic evaluations of AD therapies.
format Online
Article
Text
id pubmed-4546035
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45460352015-08-23 Clinical management and associated costs for moderate and severe Alzheimer’s disease in urban China: a Delphi panel study Yu, Xin Chen, Shengdi Chen, Xiaochun Jia, Jianjun Li, Chunhou Liu, Cong Toumi, Mondher Milea, Dominique Transl Neurodegener Research BACKGROUND: Healthcare resource utilisation for Alzheimer’s disease (AD) in China is not well understood. This Delphi panel study aimed to describe the clinical management pathways for moderate and severe AD patients in urban China and to define the amount and cost of healthcare resources used. METHODS: A panel of 11 experts was recruited from urban China to participate in two rounds of preparatory interviews. In the first round, 9 physicians specialised in dementia gave a qualitative description of the clinical management of AD patients. In the second round, 2 hospital administrators were asked about the cost of AD management and care. Results from the interviews were discussed by the experts in a Delphi panel meeting, where consensus was reached on quantitative aspects of AD management, including the rate of healthcare resource utilisation, the respective unit costs and caregiving time. RESULTS: Interviewees reported that mild AD is under-recognised in China; most patients are diagnosed with moderate to severe AD. Loss of independence and agitation/aggression are the main drivers for healthcare resource utilisation and contribute to a heavier caregiver burden. It was estimated that 70 % moderate AD patients are independent/non-aggressive at the time of diagnosis, 15 % are independent/aggressive, 10 % are dependent/non-aggressive, and 5 % are dependent/aggressive. Dependent/aggressive AD patients are more likely to be hospitalised (70–90 %) than accepted in a nursing home (0–20 %), while the opposite is true for dependent/non-aggressive patients (5–35 % for hospitalisation vs. 80 % for nursing home). Independent AD patients require 1–3 hours/day of caregiver time, while dependent patients can require up to 12–15 hours/day. Experts agreed that AD complicates the management of age-related comorbidities, found in 70–80 % of all AD patients, increasing the frequency and cost of hospitalisation. CONCLUSIONS: The Delphi panel approach was an efficient method of gathering data about the amount of healthcare resources used and associated costs for moderate and severe AD patients in urban China. The results of this study provide a useful source of information for decision makers to improve future healthcare policies and resource planning, as well as to perform economic evaluations of AD therapies. BioMed Central 2015-08-20 /pmc/articles/PMC4546035/ /pubmed/26301090 http://dx.doi.org/10.1186/s40035-015-0038-9 Text en © Yu et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Yu, Xin
Chen, Shengdi
Chen, Xiaochun
Jia, Jianjun
Li, Chunhou
Liu, Cong
Toumi, Mondher
Milea, Dominique
Clinical management and associated costs for moderate and severe Alzheimer’s disease in urban China: a Delphi panel study
title Clinical management and associated costs for moderate and severe Alzheimer’s disease in urban China: a Delphi panel study
title_full Clinical management and associated costs for moderate and severe Alzheimer’s disease in urban China: a Delphi panel study
title_fullStr Clinical management and associated costs for moderate and severe Alzheimer’s disease in urban China: a Delphi panel study
title_full_unstemmed Clinical management and associated costs for moderate and severe Alzheimer’s disease in urban China: a Delphi panel study
title_short Clinical management and associated costs for moderate and severe Alzheimer’s disease in urban China: a Delphi panel study
title_sort clinical management and associated costs for moderate and severe alzheimer’s disease in urban china: a delphi panel study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546035/
https://www.ncbi.nlm.nih.gov/pubmed/26301090
http://dx.doi.org/10.1186/s40035-015-0038-9
work_keys_str_mv AT yuxin clinicalmanagementandassociatedcostsformoderateandseverealzheimersdiseaseinurbanchinaadelphipanelstudy
AT chenshengdi clinicalmanagementandassociatedcostsformoderateandseverealzheimersdiseaseinurbanchinaadelphipanelstudy
AT chenxiaochun clinicalmanagementandassociatedcostsformoderateandseverealzheimersdiseaseinurbanchinaadelphipanelstudy
AT jiajianjun clinicalmanagementandassociatedcostsformoderateandseverealzheimersdiseaseinurbanchinaadelphipanelstudy
AT lichunhou clinicalmanagementandassociatedcostsformoderateandseverealzheimersdiseaseinurbanchinaadelphipanelstudy
AT liucong clinicalmanagementandassociatedcostsformoderateandseverealzheimersdiseaseinurbanchinaadelphipanelstudy
AT toumimondher clinicalmanagementandassociatedcostsformoderateandseverealzheimersdiseaseinurbanchinaadelphipanelstudy
AT mileadominique clinicalmanagementandassociatedcostsformoderateandseverealzheimersdiseaseinurbanchinaadelphipanelstudy